Moreover, targeting Bcl-xL by BH3-mimetics interferes with survival of epithelial as well as mesenchymal cell populations and also reduced the growth of RAS-transformed MSP cells in tumor xenografts. The gene discussed is BCL2L1; the disease is neoplasm.